PepGen to Participate in the Stifel 2023 CNS Days Conference

Rhea-AI Summary

PepGen Inc. (Nasdaq: PEPG), a biotechnology company focused on oligonucleotide therapies, announced that its President and CEO, James McArthur, Ph.D., will present at Stifel’s CNS Days Conference on March 28, 2023, at 1:30 PM EST. The event aims to showcase PepGen's innovative approach to treating severe neuromuscular and neurological diseases through its Enhanced Delivery Oligonucleotide (EDO) platform, which leverages cell-penetrating peptides. A live webcast of the presentation will be available, with an archive for one year on PepGen's Investor Relations website.

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel’s CNS Days Conference on Tuesday, March 28^th at 1:30pm EST.

The event will be webcast live under the Events & Presentations section of the Investor Relations section of PepGen’s website. A replay of the event will be archived for one year.

About PepGen

PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.

Investor Contact
Laurence Watts
Gilmartin Group
Laurence@gilmartinir.com  

Media Contact
Gwendolyn Schanker
LifeSci Communications
gschanker@lifescicomms.com

FAQ

When is James McArthur's presentation at Stifel’s CNS Days Conference?

James McArthur's presentation will take place on March 28, 2023, at 1:30 PM EST.

What is PepGen's focus as a biotechnology company?

PepGen focuses on advancing oligonucleotide therapies for severe neuromuscular and neurological diseases.

How can I watch the Stifel’s CNS Days Conference presentation by PepGen?

The conference presentation will be webcast live and can be accessed on PepGen's Investor Relations website.

What platform does PepGen utilize for its oligonucleotide therapies?

PepGen uses the Enhanced Delivery Oligonucleotide (EDO) platform, which enhances uptake through cell-penetrating peptides.

Is there a replay available for the PepGen conference presentation?

Yes, a replay of the presentation will be archived for one year on PepGen's website.